COVID-19 reinfections show similar severity to original cases, study finds
A recent study suggests that if you get reinfected with the virus that causes COVID-19, the severity of the second infection will likely be...
Scientists develop “invisible mask” to block 99.8% of airborne viruses
A groundbreaking invention by a University of Michigan startup, Taza Aya, has introduced a new way to protect workers from airborne viruses.
This technology, called...
How dexamethasone saves lives in severe COVID-19
Dexamethasone has become a crucial drug in treating severe COVID-19, but patients' responses to it vary widely.
Researchers at the German Center for Neurodegenerative Diseases...
Why older people suffer more from severe COVID-19
For over four years, a crucial question has puzzled researchers in the fight against COVID-19: Why does the infection cause severe disease in older...
Think you have COVID? Wait two days to test for better accuracy
If you feel COVID-19 symptoms, you might be tempted to test right away.
However, new research suggests that waiting two days could give you a...
Why some people don’t get COVID-19
Researchers at Massachusetts General Hospital have uncovered a promising new approach to stroke therapy using non-invasive laser light treatment. Published in the journal Stroke, this...
Common causes of cystic fibrosis people should know
Cystic fibrosis (CF) is a genetic disorder that mainly affects the lungs and digestive system, leading to severe respiratory and nutritional issues.
It's a condition...
Best time to use rapid tests for COVID-19, flu, and RSV
In many U.S. households, leftover COVID tests have become a common sight.
When symptoms of illness appear, questions naturally follow: When should I test? How...
Cannabis use linked to increased risk of severe COVID-19
A recent study by researchers at Washington University School of Medicine in St. Louis sheds new light on the risks associated with cannabis use...
Extended Paxlovid course safe but ineffective for long COVID symptoms, shows study
A recent clinical trial by Stanford Medicine researchers has found that while a 15-day course of Paxlovid, an antiviral drug for COVID-19, is safe,...